阿奇霉素联合丙酸氟替卡松治疗肺炎支原体感染所致小儿慢性咳嗽的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (659 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Azithromycin combined with Fluticasone Propionate on pediatric chronic cough caused by Mycoplasma pneumoniae (MP) infection. Methods A total of 126 children with MP infection and chronic cough admitted to the Department of Neonatology, the First Affiliated Hospital of Guangxi University of Science and Technology from September 2018 to August 2019 were selected as the research objects, and they were divided into observation group and control group by random number table method, 63 cases in each group. The control group was treated by Azithromycin, and the observation group was given the same but combined with Fluticasone Propionate. The clinical efficacy, fractional exhaled nitric oxide (FeNO), C-reactive protein (CRP), eosinophil (EOS) counts,and cough relapse rates of the two groups were compared. Results The total effective rate of the observation group was higher than that of the control group, the difference was statistically significant (P＜0.05). The serum CRP, EOS and FeNO in the observation group were lower than those of the control group, the differences were statistically significant(P＜0.05). The recurrence rate of cough in the observation group was lower than that in the control group, the difference was statistically significant (P＜0.05). Conclusion The treatment of Azithromycin combined with Fluticasone Propionate in children with chronic cough with MP infection can further improve the treatment effect and reduce the recurrence.

Key words： Azithromycin Fluticasone Propionate Mycoplasma pneumoniae infection Children with chronic cough;Effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Xiaoling
	HUANG Cuilan
	WANG Zhenchun

Cite this article:

WU Xiaoling,HUANG Cuilan,WANG Zhenchun. Clinical effect of Azithromycin combined with Fluticasone Propionate on pediatric chronic cough caused by Mycoplasma pneumoniae infection[J]. 中国当代医药, 2022, 29(2): 116-118.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2022/V29/I2/116

[1]	孟庆灿.孟鲁斯特钠与阿奇霉素治疗肺炎支原体感染致慢性咳嗽患儿[J].实用中西医结合临床，2020，20（8）：38-39.
[2]	陈霞，龙珍，黄洋，等.丙酸氟替卡松联合孟鲁司特钠辅助治疗肺炎支原体感染所致婴幼儿慢性咳嗽的效果分析[J].中国当代医药，2018，25（16）：164-167.
[3]	江载芳，申昆玲，沈颖.禇福棠实用儿科学（第8 版）[M].北京：人民卫生出版社，2015：367-368.
[4]	中华医学会儿科学分会呼吸学组慢性咳嗽协作组，《中国实用儿科杂志》编辑委员会.中国儿童慢性湿性咳嗽的诊断与治疗专家共识（2019年版)[J].中国实用儿科杂志，2019，34（4）：256-264.
[5]	沈凤祥.孟鲁斯特、辅舒酮气雾剂、万托林气雾剂联合治疗儿童过敏性咳嗽的疗效分析[J].北方药学，2018，15（2）：102-103.
[6]	王飞，季涛云，王亚军，等.咳嗽变异性哮喘患儿血清总IgE、VEGF、IL-4、IL-5、IL-13 及外周血EOS 表达水平与临床意义[J].临床肺科杂志，2019，24（2）：266-270.
[7]	杨兴春，王霞.浅谈肺炎支原体感染诱发咳嗽变异性哮喘的临床分析[J].临床医药文献电子杂志，2019，6（1）：70.
[8]	董文晖，钱萌萌，肖青.小儿慢性咳嗽与肺炎支原体感染的相关性临床分析[J].当代医学，2019，25（20）：173-175.
[9]	朱敬静.丙酸氟替卡松气雾剂吸入治疗小儿肺炎支原体感染所致慢性咳嗽的临床效果分析[J].系统医学，2020，5（5）：16-18.
[10]	李公英，黄动叶.丙酸氟替卡松气雾剂治疗肺炎支原体感染所致慢性咳嗽的效果[J].河南医学研究，2020，29（25）：4707-4709.
[11]	陈婧.丙酸氟替卡松气雾剂吸入治疗小儿肺炎支原体感染所致慢性咳嗽的临床效果分析[J].中国现代药物应用，2019，13（12）：110-111.
[12]	郭非.丙酸氟替卡松气雾剂吸入治疗婴幼儿肺炎支原体引起慢性咳嗽疗效分析[J].首都食品与医药，2017，24（18）：83.
[13]	成英姿.白三烯受体拮抗剂联合丙酸氟替卡松气雾剂对咳嗽变异性哮喘患儿肺功能及复发率的影响[J].实用中西医结合临床，2021，21（3）：35.
[14]	杨晋健，粱颖达，潘洁红.腺样体肥大患儿应用丙酸氟替卡松喷剂对血清变态反应及应激指标的影响观察[J].齐齐哈尔医学院学报，2019，40（10）：1250-1252.
[15]	喜雷，王亚君，卢旭.储雾罐吸入丙酸氟替卡松气雾剂对毛细支气管炎预后的效果评价[J].中国儿童保健杂志，2019，27（12）：1358-1361.